Global X Genomics & Biotechnology ETF
Global X Genomics & Biotechnology ETF reported 53 holdings worth US$55.8M as of May 31, 2026 (Form N-PORT)
As of May 31, 2026 · Filed Jul 29, 2026
Global X Genomics & Biotechnology ETF reported 53 holdings worth US$55.8M as of May 31, 2026. Largest: Guardant Health, Inc., Illumina, Inc. and Natera, Inc. Filed Jul 29, 2026 (Form N-PORT).
- Holdings
- 53
- Value as reported
- US$55.8M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Guardant Health, Inc. | 24,059 | US$3.12M | 5.6% |
| Illumina, Inc. | 16,512 | US$2.69M | 4.8% |
| Natera, Inc. | 10,370 | US$2.32M | 4.2% |
| Biomarin Pharmaceutical Inc. | 39,792 | US$2.28M | 4.1% |
| Arrowhead Pharmaceuticals, Inc. | 29,150 | US$2.27M | 4.1% |
| Praxis Precision Medicines, Inc. | 6,388 | US$2.24M | 4.0% |
| Twist Bioscience Corporation | 33,087 | US$2.21M | 4.0% |
| Vertex Pharmaceuticals Incorporated | 4,923 | US$2.2M | 3.9% |
| Crispr Therapeutics Ag | 38,191 | US$2.15M | 3.8% |
| Veracyte, Inc. | 43,807 | US$2.03M | 3.6% |
| Qiagen N.v. | 53,909 | US$1.97M | 3.5% |
| Bio-techne Corp | 36,783 | US$1.9M | 3.4% |
| Moderna, Inc. | 38,755 | US$1.83M | 3.3% |
| 10x Genomics, Inc. | 63,665 | US$1.8M | 3.2% |
| Beam Therapeutics Inc. | 52,306 | US$1.72M | 3.1% |
| Eli Lilly And Company | 1,169 | US$1.29M | 2.3% |
| Ultragenyx Pharmaceutical Inc. | 52,426 | US$1.26M | 2.2% |
| Caris Life Sciences, Inc. | 67,748 | US$1.13M | 2.0% |
| Genscript Biotech Corporation | 639K | US$1.12M | 2.0% |
| Billiontoone, Inc. | 11,121 | US$1.1M | 2.0% |
| Gilead Sciences, Inc. | 8,107 | US$1.09M | 2.0% |
| Astrazeneca Plc | 5,490 | US$1.02M | 1.8% |
| Sarepta Therapeutics, Inc. | 56,133 | US$1M | 1.8% |
| Uniqure N.v. | 31,188 | US$890K | 1.6% |
| Intellia Therapeutics, Inc. | 63,134 | US$888K | 1.6% |
| Stoke Therapeutics, Inc. | 26,232 | US$811K | 1.5% |
| Genedx Holdings Corp. | 14,482 | US$753K | 1.3% |
| Danaher Corporation | 3,573 | US$653K | 1.2% |
| Bristol-myers Squibb Company | 11,273 | US$645K | 1.2% |
| Vir Biotechnology, Inc. | 64,900 | US$619K | 1.1% |
| Caredx, Inc. | 25,735 | US$587K | 1.1% |
| Wave Life Sciences Ltd. | 87,259 | US$574K | 1.0% |
| Personalis, Inc. | 38,475 | US$439K | 0.79% |
| Maravai Lifesciences Holdings, Inc. | 58,810 | US$282K | 0.51% |
| Bruker Corporation | 4,056 | US$239K | 0.43% |
| Pacific Biosciences Of California, Inc. | 151K | US$226K | 0.40% |
| Benitec Biopharma Inc. | 18,350 | US$212K | 0.38% |
| Agilent Technologies, Inc. | 1,553 | US$210K | 0.38% |
| Fulgent Genetics, Inc. | 11,030 | US$200K | 0.36% |
| Standard Biotools Inc. | 171K | US$196K | 0.35% |
| Myriad Genetics, Inc. | 48,961 | US$194K | 0.35% |
| Editas Medicine, Inc. | 54,725 | US$189K | 0.34% |
| Prime Medicine, Inc. | 53,111 | US$189K | 0.34% |
| Regenxbio Inc. | 25,888 | US$181K | 0.33% |
| Rocket Pharmaceuticals, Inc. | 57,609 | US$177K | 0.32% |
| Mesa Laboratories, Inc. | 1,589 | US$162K | 0.29% |
| Caribou Biosciences, Inc. | 68,184 | US$161K | 0.29% |
| Quest Diagnostics Incorporated | 789 | US$154K | 0.28% |
| Arcturus Therapeutics Holdings Inc. | 0 | US$0 | 0.00% |
| Sangamo Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Atrium Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Alnylam Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Sana Biotechnology, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related